The BOLSTER trial is a nurse-led telehealth intervention for patients with peritoneal carcinomatosis and their caregivers. Dana-Farber’s Rachel Pozzar, PhD, RN, discusses the data presented this year at annual Society of Gynecologic Oncology meeting.
Video published: 3/22/24
Categories
Rachel Pozzar, PhD, RN on BOLSTER trial | Dana-Farber Cancer Institute [Video]
